Publicaciones en colaboración con investigadores/as de Hospital del Bierzo (1)

2013

  1. Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers

    BMC Neurology, Vol. 13